Katalis is conducting a scoping study on pharmaceutical products and complementary medicine, to identify products with potential to increase trade and investment between Indonesia and Australia. The study will examine the industrial landscape, buyer characteristics, and the market in each country. It will also provide a comprehensive understanding of the policy and legal environment for bilateral trade in the identified products.